Global home infusion therapy market

Home Infusion Therapy Market Size, Share, Growth Analysis, By Indication Analysis(Enteral Nutrition, Anti-Infective, Chemotherapy, Parenteral Nutrition), By Product Analysis(Devices, Drugs, Services), By Region - Industry Forecast 2024-2031

Report ID: SQSG35J2007 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 67 | Figures: 75

Home Infusion Therapy Market News

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Home Infusion Therapy Market size was valued at USD 43.35 billion in 2019 and is poised to grow from USD 45.41 billion in 2023 to USD 65.2 billion by 2031, growing at a CAGR of 4.63% in the forecast period (2024-2031).

The home infusion therapy market is competitive with the presence of several large players. R&D for new product launches and mergers & acquisitions are the key focus of well-entrenched players in the home infusion therapy market. For instance, in December 2021, Baxter International announced the purchase of Hillstrom. It will help the firm extend its reach while also integrating medical device innovations to improve patient care, save costs, and streamline operations. 'B. Braun Melsungen AG', 'Baxter International Inc.', 'Fresenius Kabi AG', 'ICU Medical, Inc.', 'Smiths Medical, Inc.', 'CareFusion Corporation', 'Terumo Corporation', 'Caesarea Medical Electronics Ltd.', 'JMS Co., Ltd.', 'Eli Lilly and Company', 'Pfizer Inc.', 'Novartis AG', 'Johnson & Johnson', 'Becton, Dickinson and Company', 'Roche Holding AG', 'Cigna Corporation', 'Optum, Inc.', 'Medtronic Plc', '3M Company', 'Omnicell, Inc.'

Globally, the burden of chronic diseases is rising quickly. The prevalence of diseases like cancer, diabetes, congestive heart failure, and chronic immunological weaknesses has significantly increased. This is expected to result in a large patient population with chronic illnesses and patients receiving infusion therapy in residential settings.

Residential medical care is increasingly the preferred option for patients as the healthcare industry has undergone a significant transformation in recent years. Patients and healthcare professionals are gradually fluctuating as non-critical diseases are treated in home care settings are examples of outpatient settings. several private and for-profit businesses have gotten into the service industry and are preparing medical staff to deliver the benefits of infusion treatment for patients at home.

The home infusion therapy market in North America was valued at US$ 16.90 billion in 2021, as a result of the region's high uptake of the therapy and the presence of major companies. Additionally, a rising number of patients choosing infusion therapy at home is probably going to boost the industry in the area.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Infusion Therapy Market
Buy Now GET FREE SAMPLE
Infusion Pump Market
Buy Now GET FREE SAMPLE
Intravenous Infusion Pump Market
Buy Now GET FREE SAMPLE
Perfusion System Market
Buy Now GET FREE SAMPLE
Plasma Therapy Market
Buy Now GET FREE SAMPLE
Homeopathic Medicine Market
Buy Now GET FREE SAMPLE
Cell Therapy Market
Buy Now GET FREE SAMPLE
Home Healthcare Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global home infusion therapy market

Report ID: SQSG35J2007

$5,300
BUY NOW GET FREE SAMPLE